CONCORD BIOTECH
Back to Cashflow Statement
|
CONCORD BIOTECH Last 5 Year Cash Flow from Operating Activities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Cash Flow from Operating Activities | ₹245 Cr | ₹265 Cr | ₹246 Cr | ₹207 Cr | ₹167 Cr |
What is the latest Cash Flow from Operating Activities ratio of CONCORD BIOTECH ?
| Year | Cash Flow from Operating Activities |
|---|---|
| Mar2025 | ₹245 Cr |
| Mar2024 | ₹265 Cr |
| Mar2023 | ₹246 Cr |
| Mar2022 | ₹207 Cr |
| Mar2021 | ₹167 Cr |
How is Cash Flow from Operating Activities of CONCORD BIOTECH Trending?
| Years | Cash Flow from Operating Activities | % Change | |
|---|---|---|---|
| Mar2025 | ₹245 Cr | -7.89 | |
| Mar2024 | ₹265 Cr | 7.91 | |
| Mar2023 | ₹246 Cr | 18.57 | |
| Mar2022 | ₹207 Cr | 24.37 | |
| Mar2021 | ₹167 Cr | - | |
Compare Cash Flow from Operating Activities of peers of CONCORD BIOTECH
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| CONCORD BIOTECH | ₹14,014.3 Cr | 0% | -4.2% | -37% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹412,494.0 Cr | -0.5% | -1.9% | -3% | Stock Analytics | |
| DIVIS LABORATORIES | ₹170,514.0 Cr | 1.8% | 1.3% | 10.8% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹129,044.0 Cr | 2% | 2.4% | 11.2% | Stock Analytics | |
| CIPLA | ₹121,574.0 Cr | -0.2% | -0.7% | 1.9% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹105,919.0 Cr | -1% | 2.5% | -4.4% | Stock Analytics | |
CONCORD BIOTECH Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| CONCORD BIOTECH | 0% |
-4.2% |
-37% |
| SENSEX | 0.7% |
0.5% |
9% |
You may also like the below Video Courses